Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri).

Although patients with evidence of disease reactivation were younger in our cohort, this did not reach statistical significance as reported in earlier studies (Lo Re et al. 2015 ; Salhofer‐Polanyi et al. 2014 ).

also in 111,027 other papers